INTELLECTUAL PROPERTY

Question 1

Protecting valuable innovations and discoveries is crucial for the pharmaceutical industry.

Answer 1

INTELLECTUAL PROPERTY

Question 2

Leveraging _____ rights can provide a competitive edge and ensure continued investment in research and development.

Answer 2

INTELLECTUAL PROPERTY

Question 3

4 rights of intellectual property:

Answer 3

• PATENT
• TRADE SECRETS
• COPYRIGHT
• TRADEMARK

Question 4

___ and ___ safeguard the product bame and formulation, ensuring exclusivity in the market.

Answer 4

TRADEMARKS AND PATENTS

Question 5

Trademarks and Patents safeguard the product bame and formulation, ensuring exclusivity in the market.

Answer 5

BRAND PROTECTION

Question 6

Trademark and Patents safeguard the product ___ and ____, ensuring exclusivity in the market.

Answer 6

NAME and FORMULATION

Question 7

IP documentation support regulatory submissions and helps gain market access approvals.

Answer 7

REGULATORY APPROVALS

Question 8

Exclusive rights allow companies to promote the product’s unique features and benefits to consumers.

Answer 8

MARKETING ADVANTAGES

Question 9

Strategic IP planning extends product longevity and defends against generic competition.

Answer 9

LIFECYCLE MANAGEMENT

Question 10

IPO

Answer 10

INTELLECTUAL PROPERTY OFFICE

Question 11

It is a legal right granted by the government ti an inventor, providing them with exclusive rights to their innovation for a limited period of time.

Answer 11

PATENT

Question 12

Patent is a legal right granted by the _____ ti an inventor, providing them with exclusive rights to their innovation for a limited period of time.

Answer 12

GOVERNMENT

Question 13

It can provide wide range of inventions, including new products, processes, and compositions of matter, as long as they meet certain criteria.

Answer 13

PATENTS

Question 14

To be patentable, an invention must be ___, ____ and have a _____.

Answer 14

NOVEL
NON-OBVIOUS
PRACTICAL APPLICATION or UTILITY

Question 15

New drug molecules and compounds that demonstrate therapeutic utility and eligible for patent protection, provided they meet the requirements of novelty and non-obviousness.

Answer 15

PHARMACEUTICAL COMPOUNDS

Question 16

Specialized medical devices and delivery systems developed for administering drugs and medications can also be patented as part of the pharmaceutical innovation.

Answer 16

PHARMACEUTICAL DEVICES

Question 17

Innovative manufacturing processes and methods used to produce pharmaceutical products may be eligible for patent protection, especially if they enhance efficiency product quality.

Answer 17

PHARMACEUTICAL PROCESSES

Question 18

Patentability:

Answer 18

• SUBJECT MATTER IS PATENTABLE
• USEFUL
• NEW/NOVEL
• NON-OBVIOUS
• ENABLEMENT

Question 19

To be patentable, an invention must be new and not anticipated by prior art. The patents of evaluates novelty by comparing the claimed invention to everything publicly known before the filing.

Answer 19

NOVELTY

Question 20

The invention must also be ____ to a person having ordinary skill in the art.

Answer 20

NON-OBVIOUSNESS

Question 21

This ensures patents are not granted for trivial advances that would be naturally expected.

Answer 21

NON-OBVIOUSNESS

Question 22

Inventions must have a specific substantial, and credible use to be eligible for patent protection. The disclosed invention must provide some identifiable and tangible benefit to society.

Answer 22

UTILITY

Question 23

The patent application must be enable a person skilled in the art to make and use the invention with undue experimentation: the disclosure must provide enough detail for others to replicate the invention.

Answer 23

ENABLEMENT

Question 24

Steps in Patent Application:

Answer 24

• INVENTION DISCLOSURE
• PRIOR ART SEARCH
• PATENT FILING

Question 25

The first step is to document the novel invention and submit an invention disclosure to the company’s patent team.

Answer 25

INVENTION DISCLOSURE

Question 26

A comprehensive search is conducted to ensure the invention is novel and non-obvious compared to existing patents and publications.

Answer 26

PRIOR ART SEARCH

Question 27

Based on the patentability assessment, a patent application is drafted and filed with the relevant patent of…

Answer 27

PATENT FILING

Question 28

Incentive for pharmaceutical companies to conduct pediatric clinical trials, extending market exclusivity by an additional 6 months.

Answer 28

PEDIATRIC EXCLUSIVITY

Question 29

Encouraging the development of drugs for rare diseases affecting fewer than 200,000 patients in the US, providing tax credits and market exclusivity.

Answer 29

ORPHAN DRUG DESIGNATIONS

Question 30

These programs aims to address critical gaps in treatment options for children and patients with rare, debilitating conditions.

Answer 30

UNMET MEDICAL NEEDS

Question 31

Such as therapeutic proteins and monoclonal antibodies, are complex molecules derived from living cells.

Answer 31

BIOLOGICAL PRODUCTS

Question 32

Are highly similar versions of these biologics, developed after the original patent expires

Answer 32

BIOSIMILARS

Question 33

BIOSIMILAR ARE ALSO KNOWN AS GENERIC DRUGS

Question 34

They must wait until key patents on a branded drug have expired before they can produce and market a generic version.

Answer 34

GENERIC DRUG

Question 35

Generic drug manufacturer must wait until key patents on a branded drug have expired before they can produce and market a generic version.

Answer 35

PATENT EXPIRATION

Question 36

Generic drug must undergo an approval process to demonstrate bio equivalence to the original brand product, meeting stringent regulatory standards.

Answer 36

REGULATORY APPROVAL

Question 37

Have the same bioavailability.

Answer 37

BIOEQUIVALENCE

Question 38

Generic manufacturers may license the right to produce a branded drug from the originator company, often under specific terms and conditions.

Answer 38

LICENSING AGREEMENTS

Question 39

IP Considerations for Pharmaceutical Generic Drugs:

Answer 39

• PATENT EXPIRATION • REGULATORY APPROVAL • LICENSING AGREEMENTS